At 12 and 24 months after treatment initiation, PLHIV with advanced HIV disease had 2.3 and 2.9 times the risk of MDR/RR-TB, respectively, consistently higher than PLHIV with CD4 cell counts ≥200 cells/μl and HIV negative individuals (Fig. 2). The gene discussed is CD4; the disease is tuberculosis.